Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Intracerebral Injection of Streptozotocin to Model Alzheimer Disease in Rats

2019; American Academy of Arts and Sciences; Volume: 9; Issue: 20 Linguagem: Inglês

10.21769/bioprotoc.3397

2331-8325

Daniel Moreira‐Silva, Robson Cristiano Lillo Vizin, Talita Martins, Tatiana Lima Ferreira, Maria Camila Almeida, Daniel Carneiro Carrettiero,

Medicinal Plants and Neuroprotection

Animal models have promoted meaningful contribution to science including Alzheimer's disease (AD) research. Several animal models for AD have been used, most of them related to genetic mutations observed in familial AD. However, sporadic form of AD, also named late-onset is the most frequent form of the disease, which is multifactorial, being influenced by genetic, environmental and lifestyle factors. Here, we describe a protocol of an AD-like pathology of the sporadic form using Wistar rats by a single bilateral intracerebroventricular (icv) injection of streptozotocin (STZ, 2 mg/kg). Icv injection of STZ induces brain resistance to insulin and other pathological alterations related to those observed in AD, such as cognitive impairment and accumulation of phosphorylated tau protein and β-amyloid in the brain. Thus, icv injection of STZ is a useful tool to investigate the pathological mechanisms and the metabolic alterations involved in AD and to propose new therapeutic approaches and neuroprotective drugs.